title: [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
authors.forename: A
authors.initials: A
authors.lastname: Saitta
authors.forename: M
authors.initials: M
authors.lastname: Bonaiuto
authors.forename: F
authors.initials: F
authors.lastname: Lanzafame
authors.forename: A
authors.initials: A
authors.lastname: Mileto
authors.forename: F
authors.initials: F
authors.lastname: Pernice
authors.forename: M
authors.initials: M
authors.lastname: Cinquegrani
authors.forename: G
authors.initials: G
authors.lastname: Mazza
authors.forename: G
authors.initials: G
authors.lastname: Micali
authors.forename: A
authors.initials: A
authors.lastname: Pangallo
authors.forename: P
authors.initials: P
authors.lastname: Fodale
mesh_terms: D000328:Adult; D000368:Aged; D001054:Apolipoproteins A / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood*; D001629:Bezafibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D001054:Apolipoproteins A; D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol; D001629:Bezafibrate
vernacular_title: Valutazione delle apoproteine A e B, delle lipoproteine e dei lipidi plasmatici durante trattamento con bezafibrato in varie forme di iperlipoproteinemia.